Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

The Experience of Women at High Risk for Breast Cancer Receiving Chemoprevention

International Society for Quality of Life Research
ISOQOL 2022

Prague, Czech Republic, October 19 - 22, 2022

Oral presentation: The experience of women at high risk for breast cancer receiving chemoprevention

Authors: Whisenant MS, Trevino Jones J, Brassil K, Williams LA, Ponce D, Kamat S, Solis E, Maliackal A, Walters A, Warlick H

Specialties: Oncology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.